Key result
Overexpression of CYP2J2 and its metabolites suppressed cardiac hypertrophy and increased ANP levels in wild-type mice but not AMPKα2(-/-) mice by enhancing Akt1 nuclear translocation.
Why the study?
Does CYP2J2 overexpression and its metabolites (EETs) attenuate cardiac hypertrophy in mice?
Population
AMPKα2(-/-) mice and wild-type mice treated with Ang II
Comparison
Overexpression of CYP2J2 in heart and/or… vs Wild-type mice without CYP2J2 overexpression or…
Design
Preclinical
Follow-up
2 weeks
Authors
Loading...
Hypothesis-generating in mice; leaves open translation of CYP2J2-EETs effects via AMPK-Akt to human hypertrophy.
Does CYP2J2 overexpression and its metabolites (EETs) attenuate cardiac hypertrophy in mice?
CYP2J2 and its metabolites protect against cardiac hypertrophy by enhancing Akt1 nuclear translocation through interaction with AMPKα2β2γ1.
Wang et al. (2016) studied Cardiac hypertrophy. Overexpression of CYP2J2 and 11,12-EET vs. Wild-type mice without overexpression / AMPKα2(-/-) mice was evaluated on Cardiac hypertrophy and levels of atrial natriuretic peptide (ANP). Overexpression of CYP2J2 and its metabolites suppressed cardiac hypertrophy and increased ANP levels in wild-type mice but not AMPKα2(-/-) mice by enhancing Akt1 nuclear translocation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: